This Government Contract opportunity from Department Of Defense was posted on May 28, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Pharmaceutical Manufacturing of Furosemide Injection, USP

Closed

Federal

Submission Closed06/03/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

METOPROLOL TARTRATEThe contract pertains to the procurement of Metoprolol Tartrate, identified by the National Stock Number 6505-01-615-1537, with a requested quantity of one unit under purchase request number 7017142424. The solicitation, numbered SPE2DP-26-T-3815, was posted by the Defense Logistics Agency, a branch of the Department of Defense, on June 16, 2026. The deadline for responses to this solicitation is June 22, 2026, indicating a brief window for bid submissions. This contract is categorized as a solicitation from a federal agency, with no specified type of set-aside or NAICS code provided. The place of performance and office location details are unspecified beyond being within the United States. The solicitation is accessible through the Defense Logistics Agency’s bidding system, and it appears focused on securing this specific pharmaceutical item for defense-related use.

Defense Logistics Agency

POSTED

DEADLINE

Wound Infection Prevention & Sepsis Countermeasure DevelopmentThe contract involves the development of a drug/device combination product aimed at preventing or treating wound infections and sepsis specifically in battlefield or austere environments. The project is targeted to advance this product to Phase I clinical trials under the FDA 505(b)(2) regulatory pathway, which facilitates the approval process by leveraging existing data. This effort is intended to address critical medical needs encountered by military personnel in challenging settings, ensuring rapid and effective countermeasures against potentially life-threatening infections. Issued by the Army Medical Resources Acquisition Activity under the Department of Defense, the contract is a subcontract with a focus on the pharmaceutical manufacturing sector (NAICS code 325412). The work will be performed in Frederick, capturing the strategic importance of this location for medical research and development. The solicitation was posted on June 16, 2026, with a response deadline of July 17, 2026, highlighting a clear and concise timeline for interested parties. This project underscores a high-priority initiative to enhance battlefield medical capabilities through innovative therapeutic solutions.

Army Medical Resources Acq Activity

POSTED

DEADLINE

Supply of QIAamp Viral RNA Mini KitsThe contract involves the supply of eight kits specifically designed for viral RNA extraction from clinical samples, identified as QIAamp Viral RNA Mini Kits. Issued by the U.S. Embassy in Tbilisi under the Department of State, this subcontract is categorized under the NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. The procurement process was initiated on June 16, 2026, with a response deadline set for July 6, 2026. The performance location for delivery is in Tbilisi, with a designated postal code of 0186. This contracting opportunity does not specify a solicitation number, type of set-aside, or further details on organization type or points of contact. It is a straightforward supply contract aimed at equipping the designated facility in Tbilisi with essential kits for viral RNA extraction, which are critical for clinical diagnostics and research related to viral pathogens. The contract is accessible through a dedicated link on the federal contracting platform, indicating transparency and open competition in the procurement process.

POSTED

DEADLINE

6505--Dutasteride CapsulesThe Department of Veterans Affairs National Acquisition Center plans to issue a Request for Proposal (RFP 36E79726R0029) for the procurement of Dutasteride Capsules to serve multiple federal agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This unrestricted contract aims to secure a reliable supply source for Dutasteride 0.5MG capsules in both 30-count and 90-count bottles, with annual estimated usage of approximately 3,912 and 25,502 bottles respectively. The contract will be awarded to a single responsible offeror who can provide an uninterrupted supply and will have a one-year base period followed by four one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must supply the drug under the exact name on the label, with a unique National Drug Code (NDC) exclusive to the offeror. The contractor’s label must be the sole label on the product, with VA labels designed to adhere securely on top without obscuring important information such as barcodes, expiration dates, and lot numbers. Packaging requirements include safety caps that meet specific design criteria with a minimum bottle volume of 120cc and cylindrical shape to accommodate appropriate labeling sizes. The solicitation will be released in a commercial item format in accordance with FAR Part 12 around June 22, 2026, with proposals due by July 7, 2026. Interested parties should monitor SAM.gov for updates and submit offers electronically; efforts to obtain paper copies will not be accommodated. The contract specialist and primary point of contact for this procurement is Richard Mahario.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

Supply of Diagnostic PCR Kits (Zika, Dengue, Chikungunya)This contract involves the supply of one kit of the VIASURE Real-Time PCR Kit designed for the simultaneous detection of Zika, Dengue, and Chikungunya viruses. The contract is a subcontract opportunity posted by the US Embassy in Tbilisi under the Department of State. The solicitation was made public on June 16, 2026, with a response deadline set for July 6, 2026. The contract falls under the NAICS code 325412, indicating it pertains to pharmaceutical preparation manufacturing. The kit is intended for use in Tbilisi, Georgia, and aims to facilitate efficient diagnostic testing for these three viruses in a single assay. This opportunity does not specify any set-aside requirements, and detailed contact information is not provided. The purpose is to enhance diagnostic capabilities in the region through timely and reliable detection of these mosquito-borne illnesses.

US Embassy Tbilisi

POSTED

1 day ago

DEADLINE

in 19 days

AI Contract Overview

The contract entails the manufacture and supply of sterile, preservative-free Furosemide Injection, USP, provided in 2 mL single-dose vials at a concentration of 10 mg/mL. The production must adhere to stringent standards set by the FDA, USP, and the Defense Logistics Agency (DLA), ensuring compliance with regulatory and quality requirements. The contract is a subcontract issued by the Department of Defense through the Medical Supply Chain Pharm FSA, focusing on pharmaceutical manufacturing under NAICS code 325412. The solicitation was posted on May 28, 2026, with a response deadline of June 3, 2026. The place of performance is listed as FPO with zip code 96667, and it involves supplying the product to meet federal medical supply needs. This contract seeks qualified manufacturers capable of producing high-quality sterile injections to support defense medical logistics.

General Info

Manufacture and supply sterile Furosemide Injection, 2 mL vials, FDA and DLA compliant for DoD.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

FPO, AP, 96667, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed

PostedMay 28

subcontract

Response DeadlineJun 3

Deadline has passed

Submission Closed

06/03/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressN/A

ContactsNo contact information available

Full Description

Manufacture and supply of sterile, preservative-free Furosemide Injection, USP in 2 mL single-dose vials at 10 mg/mL concentration, compliant with FDA, USP, and DLA standards.

Bluestone Government Services CorpUEI: F9H2D7S5V3A1CAGE: 7P1R4$891,234View Profile

Bluestone Government Services CorpUEI: F9H2D7S5V3A1CAGE: 5A3C7$31,089,772View Profile

Bluestone Government Services CorpUEI: M1P3R5T7V9X2CAGE: 3K5M8$2,847,391View Profile

Pinnacle Systems International IncUEI: B3N5T1W8J6L4CAGE: 9X7Z2$14,562,088View Profile

Pinnacle Systems International IncUEI: X7K9M2R4P6Q8CAGE: 3K5M8$31,089,772View Profile